ASSOCIATION OF PTPN22 RS2476601 (1858C>T) POLYMORPHISM WITH SUSCEPTIBILITY AND DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS: A CASE-CONTROL STUDY FROM UZBEKISTAN
Keywords:
rheumatoid arthritis, PTPN22, rs2476601, genetic polymorphism, disease activity, DAS28, SDAI, Uzbek population, PCR-RFLP, autoimmune disease.Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by persistent synovial inflammation and progressive joint destruction. Its etiology is multifactorial, involving complex interactions between genetic predisposition, environmental triggers, and immunological dysregulation. Among the candidate genes implicated in RA pathogenesis, PTPN22 (protein tyrosine phosphatase, non-receptor type 22) has emerged as a critical regulator of T-cell receptor (TCR) signaling and a recognized susceptibility locus across diverse ethnic populations. However, data on PTPN22 polymorphism in Central Asian populations, including the Uzbek population, remain scarce. In the present study, we investigated the association of the PTPN22 1858C>T single nucleotide polymorphism (rs2476601) with RA susceptibility in an Uzbek cohort. A total of 118 RA patients, diagnosed according to the 2010 ACR/EULAR classification criteria, and 80 healthy controls of matched ethnicity and socioeconomic background were recruited from rheumatology centers in Uzbekistan. Genotyping was performed using the PCR-RFLP method with XcmI restriction enzyme digestion. Genotype frequencies, allele distributions, and carriage rates were compared between patient and control groups using chi-square and Fisher’s exact tests. Our findings revealed a statistically significant difference in the distribution of PTPN22 genotypes between RA patients and healthy controls (p=0.027). The T allele and CT/TT genotype carriage were found at significantly higher frequency in RA patients compared to controls (OR=2.17, 95% CI: 1.21–3.89; p=0.009), suggesting a meaningful association with RA susceptibility in the Uzbek population. Notably, the CC genotype was significantly associated with higher disease activity as assessed by DAS28 and SDAI scores (p<0.01). The T allele frequency in our cohort (11.4%) was lower than that reported in European populations, reflecting the distinct genetic background of the Uzbek population. This study represents the first investigation of PTPN22 rs2476601 polymorphism in RA patients from Uzbekistan, and supports the role of this variant as a potential genetic marker of RA susceptibility and disease severity in Central Asia.References
Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002;4(Suppl 3):S265–S272.
MacGregor AJ, Snieder H, Rigby AS, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43(1):30–37.
Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin Immunol. 2006;18(4):207–213.
Cloutier JF, Veillette A. Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med. 1999;189(1):111–121.
Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Semin Immunol. 2006;18(4):214–223.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
Shukla S, Tripathi AK, Tripathi JK, Indurkar M, Chauhan UK. Role of PTPN22 and VDR gene polymorphisms in susceptibility to rheumatoid arthritis: a study from central India. Adv Genomics Genet. 2014;4:79–85.
Begovich AB, Carlton VE, Honigberg LA, et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am J Hum Genet. 2004;75(2):330–337.
Steer S, Lad B, Grumley JA, Kingsley GH, Fisher SA. Association of R620W in a protein tyrosine phosphatase gene with a high risk of rheumatoid arthritis in a British population: evidence for an early onset/disease severity effect. Arthritis Rheum. 2005;52(1):358–360.
Mastana S, Gilmour A, Ghelani A, Smith H, Samanta A. Association of PTPN22 with rheumatoid arthritis among South Asians in the UK. J Rheumatol. 2007;34(10):1984–1986.
Buranova S.N. (2026). IMMUNOLOGICAL FEATURES AND CYTOKINE PROFILE IN SYSTEMIC SCLEROSIS AND THEIR CLINICAL SIGNIFICANCE [Data set]. Zenodo.
Khalmetova, F. I., Akhmedov, K. S., Buranova, S. N., Rakhimova, M. B., Rakhimov, S. S., & Abdurakhimova, L. A. (2023). Immunological Features of Reactive Arthritis of Various Etiologies. Journal of Coastal Life Medicine, 11, 1322-1325.
Шовкатова, М. Н., & Рахимова, М. Б. (2025). ИСКУССТВЕННЫЙ ИНТЕЛЛЕКТ В ЦИФРОВОЙ СТРАТИФИКАЦИИ И ДИНАМИЧЕСКОМ КОНТРОЛЕ СЕРДЕЧНО-СОСУДИСТОГО РИСКА У БОЛЬНЫХ С АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИЕЙ И РЕВМАТОИДНЫМ АРТРИТОМ. FARS International Journal of Education, Social Science & Humanities., 13(12), 7-14.
Rakhimova, M., Akhmedov, K., Buranova, S., & Tursunova, L. (2022). Еvaluationofcardiovascular events in patients with ankylosing spondylitis after COVID-19
Абдурахимов, А. Г., & Халметова, Ф. И. (2023). Нестероидные противовоспалительные препараты у пациентов с деформирующим остеоартрозом и артериальной гипертензией: анализ влияния целекоксиба и мелоксикама на антигипертензивные средства. Оптимизация лечения. Атеросклероз, 19(3), 186-187.
Khalmetova, Feruza; Akhmedov, Khalmurad; Tavasharov, Bahodir; Razakova, Feruza. The Role of Cartilage Oligomer Matrix Protein (COPM) in Diagnostics of Early Cartilage Destruction in Reactive Arthritis. Annals of the Romanian Society for Cell Biology; Arad Том 25, Изд. 1, (2021): 4404-4410;
Ахмедов Халмурад Садуллаевич, Абдурахманова Наргиза Мирбахтияровна, & Халметова Феруза Искандеровна (2017). Влияние различных физических факторов климата на течение ревматоидного артрита. Universum: медицина и фармакология, (3 (37)), 12-15.
